MULTIAGONISTS AND THEIR APPLICATION Russian patent published in 2025 - IPC C07K14/605 A61K38/26 A61P3/00 

Abstract RU 2833609 C2

FIELD: biotechnology.

SUBSTANCE: invention relates to biotechnology and specifically to a polypeptide compound of a triple agonist GLP-1/GIP/GCG R, or a salt thereof, or a solvate thereof, as well as a composition containing it.

EFFECT: invention is effective for treating metabolic syndrome, when preparing medicinal agents for reducing apoptosis β-cells of pancreatic islets, increase in number β-cells of pancreatic islets and improved function of islet cells of pancreas, when preparing medicinal agents for improving blood lipids, reducing fatty deposits in the liver, inhibiting the development of liver inflammation, preventing or treating non-alcoholic fatty liver disease, when preparing medicinal agents for preventing or treating metabolic disorders and related complications, when preparing medicinal agents for treating dyslipidemia and related diseases, as well as neurodegenerative diseases, as well as in the preparation of drugs for the treatment of bone diseases associated with endocrine disorders, metabolic disorders, kidney diseases.

26 cl, 10 tbl, 7 ex

Similar patents RU2833609C2

Title Year Author Number
GIP AGONIST COMPOUNDS AND METHODS 2015
  • Shelton Pernilla Tofteng
  • Norregaard Pia
  • Deryabina Mariya Aleksandrovna
  • Larsen Byarn Dyu
  • Fog Dzhejkob Ulrik
RU2716985C2
IMPROVED PEPTIDE DRUGS FOR TREATMENT OF NASH AND OTHER DISORDERS 2019
  • Nestor, John J.
RU2790209C2
MODIFIED ANALOGUES OF GIP PEPTIDE 2019
  • Sparre-Ulrikh, Aleksandr, Govard
  • Sivertsen, Born, Berens
  • Riber, Ditte
  • Rozenkilde, Mette, Mari
RU2817673C2
STRUCTURES HAVING SIRP-ALPHA DOMAIN OR ITS VERSION 2016
  • Ponz Khaume
  • Deming Laura
  • Gudman Kori
  • Sim Bang Dzhanet
  • Kauder Stiven Elliot
  • Van Khun
  • Ko Trejsi Chia-Chien
RU2740672C2
MULTI-RECEPTOR AGONIST AND MEDICAL USE THEREOF 2020
  • Wu Fangzhou
  • Wang Lei
  • Liu Xiao
  • Wu Ran
  • Hua Haiqing
  • Bao Rudi
  • Wang Xiaolei
RU2816492C2
THERAPEUTIC USE OF LONG-ACTING TRIPLE AGONIST CONJUGATE HAVING ACTIVITIES ON ALL GLUCAGON/GLP-1/GIP RECEPTORS FOR TREATING LUNG DISEASE 2020
  • Lee Seon Myeong
  • Lee Jong Suk
  • Kim Jung Kuk
  • Lee Sang Hyun
  • Oh Euh Lim
  • Jo Hyo Sang
  • Park Eun Jin
  • Lim Chong Yoon
RU2829342C1
PEPTIDE ANALOG OF ACYLATED OXYNTOMODULIN 2018
  • Che, Iu-Na
  • Li, Kajung-Seok
  • Che, Yu-Na
  • Baek, Gaje-Rim
  • Kim, Tae-Khajong
  • Yung, Ill-Khun
  • Ryu, Che-Lim
  • Im, Veon-Bin
RU2752787C1
ANTIBODY SPECIFICALLY BINDING TO ICAM-1 AND ITS USE 2019
  • Mun, Yu Ri
  • Dzhi, Gil Jong
  • Jun, Sangsun
  • Kim, Dzhung Sik
RU2789757C2
PEPTIDIC INTERLEUKIN-23 RECEPTOR INHIBITORS FOR ORAL ADMINISTRATION AND USE THEREOF FOR TREATING INFLAMMATORY INTESTINAL DISEASES 2015
  • Bourne, Gregory
  • Bhandari, Ashok
  • Cheng, Xiaoli
  • Frederick, Brian Troy
  • Zhang, Jie
  • Patel, Dinesh V.
  • Liu, David
RU2736637C2
LONG-ACTING DOUBLE AGONIST OF GLUCAGON-LIKE PEPTIDE-1 AND GLUCAGON RECEPTORS 2021
  • Yan, Che-Son
  • Li, Kyun-Sok
  • Chkhe, Yu-Na
  • Kim, Te-Khyun
  • Chon, Ill-Khun
  • Lyu, Chkhe-Lim
  • Li, Tkhe-Yun
RU2799327C1

RU 2 833 609 C2

Authors

Huang Liang

Cao Chunlai

Deng Huixing

Zhou Cui

He Xiuyi

Liu Xiaoxiao

Xie Xin

Dates

2025-01-27Published

2022-05-18Filed